Today: 29 April 2026
Browse Category

NYSE:WST 23 October 2025 - 12 January 2026

AbbVie stock slips after $650 million RemeGen cancer-drug deal and Arizona plant buy

AbbVie stock slips after $650 million RemeGen cancer-drug deal and Arizona plant buy

AbbVie shares fell 0.6% to $218.81 after announcing a $650 million licensing deal with China’s RemeGen for the experimental cancer drug RC148. RemeGen could receive up to $4.95 billion in milestones and royalties. AbbVie also agreed to buy a device manufacturing plant in Tempe, Arizona, from West Pharmaceutical Services. The S&P health-care sector declined while the broader market rose.
12 January 2026
···
Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

Stock Market Today 23.10.2025

West Pharmaceutical Services posted Q3 profit of $140 million, or $1.92 per share, beating estimates and raising FY25 guidance. Enphase Energy shares fell 11% in a month, with a 1-year total return of -54%, as valuation concerns persist. CBRE Group reported Q3 net income of $225 million and lifted full-year EPS guidance. Tractor Supply beat Q3 earnings estimates and raised its full-year EPS outlook to $2.06–$2.13.
23 October 2025
···

Stock Market Today

  • Nifty 50 and Sensex Likely to Open Higher on April 29; Market Outlook
    April 28, 2026, 10:42 PM EDT. Indian stock benchmarks Sensex and Nifty 50 are expected to open higher on April 29, reflecting mixed global cues and mildly positive trends in Gift Nifty. Despite Tuesday's declines with Sensex falling 0.54% to 76,886.91 and Nifty dipping below 24,000 to 23,995.70, market analysts forecast a cautious near-term outlook. Sensex faces support at 76,300-76,400 and resistance near 77,300-77,500, with intermittent selling pressure likely. For Nifty 50, technical indicators show a range-bound action with support around 23,800 and resistance at 24,200. Derivative data highlights a narrow trading range, with call options at 24,100 and 24,200 strikes. Experts caution that geopolitical uncertainties and global volatility may limit sharp directional moves, maintaining a slightly negative bias in the short term.

Latest article

AST SpaceMobile Stock’s May 11 Moment: FCC Win Meets BlueBird 7 Reality

AST SpaceMobile Stock’s May 11 Moment: FCC Win Meets BlueBird 7 Reality

29 April 2026
AST SpaceMobile will hold its first-quarter update call on May 11 after winning FCC approval to deploy a 248-satellite constellation for direct-to-device service. Shares fell 6.8% Tuesday, following the loss of its BlueBird 7 satellite in a failed launch. The company expects insurance to cover the loss and is targeting 45 satellites in orbit by end-2026. Investors are watching launch progress and commercial service timing.
OpenAI Target Miss Report Sends Oracle, CoreWeave and AI Stocks Lower

OpenAI Target Miss Report Sends Oracle, CoreWeave and AI Stocks Lower

29 April 2026
Oracle shares fell 4% and CoreWeave dropped 5.9% Tuesday after a Wall Street Journal report said OpenAI missed recent revenue and user targets. Nvidia, AMD, and Arm Holdings also declined, with the iShares Semiconductor ETF down 3.7%. OpenAI denied internal divisions and said its AI coding product Codex reached 4 million users. Oracle’s credit default swaps hit a two-week high amid concern over its $300 billion cloud deal with OpenAI.
Go toTop